Xarelto Internal Bleeding, Other Injury Lawsuits Moving Toward Trial

Harvey Kirk

By Harvey Kirk
Posted August 4, 2015

ADD YOUR COMMENTS 1
UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.

The lawyers at Saiontz & Kirk, P.A. represent individuals throughout the U.S. who are pursuing a Xarelto lawsuit after experiencing internal bleeding, hemorrhaging or another bleeding injury caused by the drug maker’s failure to adequately warn about the risks associated with use of the anticoagulant.

It is expected that the first Xarelto trial dates in the federal court system may start around this time next year, but time still remains to determine whether you or a loved one may be eligible for compensation as a result of a Xarelto injury.

There are currently about 2,000 failure to warn lawsuits pending against Bayer and Johnson & Johnson’s Jannsen Pharmaceuticals subsidiary over bleeding complications on Xarelto. However, our lawyers expect that there will ultimately be several thousand additional complaints filed by individuals who have suffered gastrointestinal bleeding, internal bleeding, hemorrhaging or wrongful death before the first trials begin in August 2016.

In the federal court system, the Xarelto bleeding litigation is consolidated as part of an MDL, or multidistrict litigation, where cases are centralized before U.S. District Judge Eldon Fallon in the Eastern District of Louisiana where they are being managed in a manner similar to a Xarelto class action. However, since each bleeding injury caused by Xarelto has different consequences, if a settlement is not reached, each individual case may need to go before a jury to determine the amount of damages the drug makers should be required to pay.

As part of the coordinated management of the litigation, Judge Fallon has indicated that a group of representative cases will be selected for a series of early trial dates. Known as “bellwether” trials, the outcomes of these cases will help each side gauge the relative strengths and weaknesses of their claim and determine how juries may respond to similar evidence and testimony that would be offered throughout a number of claims.

The first Xarelto trials are expected to begin in August 2016. In the meantime, the Xarelto lawyers at Saiontz & Kirk, P.A. are continuing to provide free consultations and claim evaluations to help individuals determine if they or a loved one may be eligible to join the litigation.

All cases are handled by our law firm under a contingency fee agreement, which means that there are no out-of-pocket expenses to hire a lawyer, and we only receive attorney fees or reimbursement of expenses if money is obtained in your case.

UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.

1 Comment • Add Your Comments

  • LaMar says:

    Thanks for keeping the Public informed about the pending litigation against this Drug and the Drug company

    Posted on August 20, 2015 at 3:44 pm

Add Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case.

    The information below will not be published to this page.

  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.